Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients

Table 1

Characteristics of participants before initiating the RBM treatment.

Parameters
Age, mean ± SD (range), years	64 ± 14 (32–83)
Sex (male : female)	3 : 40
DEQS questionnaire
Summary score, mean (SD), point	41.7 (22.7)
Bothersome ocular symptoms score, mean (SD), point	48.1 (23.1)
Impact on daily life score, mean (SD), point	37.7 (25.0)
Fluorescein staining score, mean (SD), point	2.3 (2.1)
Tear film breakup time score, mean (SD), s	1.9 (0.5)
Schirmer’s testing, mean (SD), mm	8.9 (10.6)